Late killing of <i>Plasmodium berghei</i> sporozoites in the liver by an anti-circumsporozoite protein antibody.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39951341.
- Also identified by DOI 10.7554/eLife.105291 and PMC identifier 11828480.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
<i>Plasmodium</i> sporozoites are inoculated into the skin during the bite of an infected mosquito. This motile stage invades cutaneous blood vessels to reach the liver and infect hepatocytes. The circumsporozoite protein (CSP) on the sporozoite surface is an important antigen targeted by protective antibodies (Abs) in immunoprophylaxis or elicited by vaccination. Antibody-mediated protection mainly unfolds during parasite skin migration, but rare and potent protective Abs additionally neutralize sporozoite in the liver. Here, using a rodent malaria model, microscopy and bioluminescence imaging, we show a late-neutralizing effect of 3D11 anti-CSP monoclonal antibody (mAb) in the liver. The need for several hours to eliminate parasites in the liver was associated with an accumulation of 3D11 effects, starting with the inhibition of sporozoite motility, sinusoidal extravasation, cell invasion, and terminating with the parasite killing inside the invaded cell. This late-neutralizing activity could be helpful to identify more potent therapeutic mAbs with stronger activity in the liver.
Medical subject headings
- Plasmodium berghei
- Sporozoites
- Liver
- Protozoan Proteins
- Antibodies, Protozoan
- Antibodies, Monoclonal
- Malaria